Biology Reference
In-Depth Information
Nowak MA, Bangham CR. 1996. Population dynamics of immune responses to persistent viruses.
Science 272: 74±79.
Ogg GS, Jin X, Bonhoe¨er S, Dunbar PR, Nowak MA, Monard S, Segal JP, Cao Y, Rowland-
Jones SL, Cerundolo V, et al. 1998. Quantitation of HIV-1-speci®c cytotoxic T lymphocytes and
plasma load of viral RNA. Science 279: 2103±2106.
Ogg GS, Jin X, Bonhoe¨er S, Moss P, Nowak MA, Monard S, Segal JP, Cao Y, Rowland-Jones
SL, Hurley A, et al. 1999a. Decay kinetics of human immunode®ciency virus-speci®c e¨ector
cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol 73: 797±800.
Ogg GS, Kostense S, Klein MR, Jurriaans S, Hamann D, McMichael AJ, Miedema F. 1999b.
Longitudinal phenotypic analysis of human immunode®ciency virus type 1-speci®c cytotoxic T
lymphocytes: correlation with disease progression. J Virol 73: 9153±9160.
Oxenius A, Price DA, Easterbrook PJ, O'Callaghan CA, Kelleher AD, Whelan JA, Sontag G,
Sewell AK, Phillips RE. 2000. Early highly active antiretroviral therapy for acute HIV-1 infec-
tion preserves immune function of CD8
and CD4
T lymphocytes. Proc Natl Acad Sci USA
97: 3382±3387.
Roederer M. 1998. Getting to the HAART of T cells dynamics. Nat Med 4: 145±146.
Rowland-Jones S, Dong T, Krausa P, Sutton J, Newell H, Ariyoshi K, Gotch F, Sabally S, Corrah
T, Kimani J, et al. 1998. The role of cytotoxic T-cells in HIV infection. Dev Biol Stand 92: 209±
214.
Rowland-Jones SL, Dong T, Dorrell L, Ogg G, Hansasuta P, Krausa P, Kimani J, Sabally S,
Ariyoshi K, Oyugi J, et al. 1999. Broadly cross-reactive HIV-speci®c cytotoxic T-lymphocytes in
highly-exposed persistently seronegative donors. Immunol Lett 66: 9±14.
Seth A, Ourmanov I, Kuroda MJ, Schmitz JE, Carroll MW, Wyatt LS, Moss B, Forman MA,
Hirsch VM, Letvin NL. 1998. Recombinant modi®ed vaccinia virus Ankara-simian immuno-
de®ciency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major
histocompatibility complex class I/peptide tetramer. Proc Natl Acad Sci USA 95: 10112±10116.
Sourdive DJ, Murali-Krishna K, Altman JD, Zajac AJ, Whitmire JK, Pannetier C, Kourilsky P,
Evavold B, Sette A, Ahmed R. 1998. Conserved T cell receptor repertoire in primary and
memory CD8 T cell responses to an acute viral infection. J Exp Med 188: 71±82.
Spiegel H, DeFalcon E, Ogg G, Larsson M, Beadle T, Tao P, McMichael A, Bhardwaj N,
O'Callaghan C, Cox W, et al. 1999. Changes in frequency of HIV-1-speci®c cytotoxic T cell
precursors and circulating e¨ectors after combination antiretroviral therapy in children. J Infect
Dis 180: 359±368.
Spiegel HM, Ogg GS, DeFalcon E, Sheehy ME, Monard S, Haslett PA, Gillespie G, Donahoe SM,
Pollack H, Borkowsky W, et al. 2000a. Human immunode®ciency virus type 1- and cytomega-
lovirus-speci®c cytotoxic T lymphocytes can persist at high frequency for prolonged periods in
the absence of circulating peripheral CD4() T cells. J Virol 74: 1018±1022.
Spiegel HM, Chandwani R, Sheehy ME, Dobroszycki J, Fennelly G, Wiznia A, Radding J, Rigaud
M, Pollack H, Borkowsky W, et al. 2000b. The impact of early initiation of highly active anti-
retroviral therapy on the human immunode®ciency virus type 1-speci®c CD8 T cell response in
children. J Infect Dis 182: 88±95.
Tan LC, Gudgeon N, Annels NE, Hansasta P, O'Callaghan CA, Rowland-Jones S, McMichael AJ,
Rickinson AB, Callan MF. 1999. A re-evaluation of the frequency of CD8
T cells speci®c for
EBV in healthy virus carriers. J Immunol 162: 1827±1835.
Tang J, Costello C, Keet IP, Rivers C, Leblanc S, Karita E, Allen S, Kaslow RA. 1999. HLA class I
homozygosity accelerates disease progression in human immunode®ciency virus type 1 infection.
AIDS Res Hum Retroviruses 15: 317±324.
Tenner-Racz K, Stellbrink HJ, van Lunzen J, Schneider C, Jacobs JP, Raschdor¨ B, Grosschup¨
G, Steinman RM, Racz P. 1998. The unenlarged lymph nodes of HIV-1-infected, asymptomatic
patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation.
The impact of highly active antiretroviral therapy. J Exp Med 187: 949±959.
